Article Information
History
- August 3, 2022.
Copyright
The copyright holder for this preprint is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Author Information
- Koen van de Ven1,
- Josien Lanfermeijer1,2,
- Harry van Dijken1,
- Hiromi Muramatsu3,
- Caroline Vilas Boas de Melo1,
- Stefanie Lenz1,
- Florence Peters1,
- Mitchell B Beattie4,
- Paulo J C Lin4,
- José A. Ferreira5,
- Judith van den Brand6,
- Debbie van Baarle1,7,
- Norbert Pardi3,* and
- Jørgen de Jonge1,*
- 1Centre for Infectious Disease Control, National Institute for Public Health and the Environment (RIVM), Bilthoven, the Netherlands
- 2Center for Translational Immunology, University Medical Center Utrecht, Utrecht, Netherlands
- 3Department of Microbiology, University of Pennsylvania, Philadelphia, PA, USA
- 4Acuitas Therapeutics, Vancouver, BC V6T 1Z3, Canada
- 5Department of Statistics, Informatics and Modelling, National Institute for Public Health and the Environment (RIVM), Bilthoven, The Netherlands
- 6Division of Pathology, Faculty of Veterinary Medicine, Utrecht University, Utrecht, Netherlands
- 7Department of Medical Microbiology and Infection prevention, Virology and Immunology research Group, University Medical Center Groningen, Groningen, Netherlands
- ↵*correspondence should be sent to pnorbert{at}pennmedicine.upenn.edu and jorgen.de.jonge{at}rivm.nl